ARTELO BIOSCIENCES INC (ARTL)
US04301G5080 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-8-31) | 2020 (2020-8-31) | 2019 (2019-8-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -9.29M | -10.08M | -7.44M | -4.65M | -2.17M | |||
| Depreciation Amortization | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Change In Working Capital | 663.00K | -220.00K | -240.00K | -40.00K | -140.00K | |||
| Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 419.00K | 2.29M | 1.54M | 350.00K | -480.00K | |||
| OPERATING CASH FLOW | -8.21M | -8.01M | -6.14M | -4.35M | -2.79M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | 0.00 | -1.50M | |||
| Other Investing Activity | 3.51M | 2.96M | -3.44M | N/A | N/A | |||
| INVESTING CASH FLOW | 3.51M | 2.96M | -3.44M | 0.00 | -1.50M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 567.00K | 0.00 | 14.12M | 1.98M | 8.38M | |||
| Other Financing Activity | N/A | 0.00 | -10.00K | 0.00 | 0.00 | |||
| FINANCING CASH FLOW | 567.00K | 0.00 | 14.11M | 1.98M | 8.38M | |||
| Exchange Rate Effect | 60.00K | -220.00K | -50.00K | 80.00K | 0.00 | |||
| CHANGE IN CASH | -4.07M | -5.27M | 4.48M | -2.29M | 4.09M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -8.21M | -8.01M | -6.14M | -4.35M | -2.79M | |||
| Capital Expenditure | N/A | N/A | N/A | 0.00 | -1.50M | |||
| FREE CASH FLOW | -8.21M | -8.01M | -6.14M | -4.35M | -4.29M | |||
All data in USD